Evidence map›Paper›PMID 40229258›Full record

ArticleBone research2025

SPI1 activates mitochondrial unfolded response signaling to inhibit chondrocyte senescence and relieves osteoarthritis.

Xiangyu Zu, Shenghong Chen, Zhengyuan Li, Lin Hao, Wenhan Fu, Hui Zhang, Zongsheng Yin, Yin Wang, Jun Wang

Abstract read
In one paragraph

Article in Bone research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiangyu Zu *Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Shenghong Chen *Department of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Zhengyuan LiDepartment of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Lin HaoDepartment of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Wenhan FuDepartment of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Hui ZhangDepartment of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Zongsheng YinDepartment of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Anhui, China. yinzongsheng@sina.com.
Yin WangDepartment of Wound Repair & Plastic and Aesthetic Surgery, the First Affiliated Hospital of Anhui Medical University, Anhui, China. wangyinzx@sina.com.
Jun WangDepartment of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Anhui, China. wangjun01@ahmu.edu.cn.ORCID http://orcid.org/0009-0007-5139-2330

Funding

Anhui Department of Education (Department of Education of Anhui Province) 2023AH053327Anhui Medical University (AHMU) 2020XKJ039Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation) 2308085MH250
6 · The paper itself

Abstract

Chondrocyte senescence is a critical pathological hallmark of osteoarthritis (OA). Aberrant mechanical stress is considered a pivotal determinant in chondrocyte aging; however, the precise underlying mechanism remains elusive. Our findings demonstrate that SPI1 plays a significant role in counteracting chondrocyte senescence and inhibiting OA progression. SPI1 binds to the PERK promoter, thereby promoting its transcriptional activity. Importantly, PERK, rather than GCN2, facilitates eIF2α phosphorylation, activating the mitochondrial unfolded protein response (UPR

Indexed as

Cellular SenescenceChondrocytesMitochondriaOsteoarthritisUnfolded Protein ResponseAnimalseIF-2 KinaseHumansMaleMiceMice, Inbred C57BLSignal TransductioneIF-2 Kinase

Identifiers

PMID40229258
PMCPMC11997156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.